Catecholamines augment collateral vessel growth and angiogenesis in hindlimb ischemia

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 2 58-2, 2005, Pages

  Chalothorn, Dan ^a   Zhang, Hua ^a   Clayton, Jason A ^a   Thomas, Steven A ^b   Faber, James E ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Arteriogenesis; Dopamine hydroxylase; Laser Doppler imaging

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA SMOOTH MUSCLE ACTIN; CATECHOLAMINE; DOPAMINE BETA MONOOXYGENASE; GROWTH FACTOR; NORADRENALIN; REACTIVE OXYGEN METABOLITE;

ADOLESCENT; ADVENTITIA; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTERY LIGATION; ARTERY MEDIA; ARTERY MUSCLE; ARTICLE; BLOOD VESSEL INJURY; CATECHOLAMINE SYNTHESIS; CELL PROLIFERATION; COLLATERAL CIRCULATION; CONTROLLED STUDY; FEMORAL ARTERY; FIBROBLAST; GASTROCNEMIUS MUSCLE; GENE DELETION; HYPERPLASIA; HYPERTROPHY; LASER DOPPLER FLOWMETRY; LEUKOCYTE; LIMB ISCHEMIA; MOUSE; MUSCLE ATROPHY; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SYMPATHETIC NERVE;

ACTINS; ANIMALS; BLOOD VESSELS; CATECHOLAMINES; COLLATERAL CIRCULATION; DOPAMINE BETA-HYDROXYLASE; HINDLIMB; ISCHEMIA; LEUKOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 23744488663     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00952.2004     Document Type: Article

References (109)

1. Alaniz RC, Thomas SA, Perez-Melgosa M, Mueller K, Farr AG, Palmiter RD, and Wilson CB. Dopamine β-hydroxylase deficiency impairs cellular immunity. Proc Natl Acad Sci USA 96: 2274-2278, 1999.
2. Asano A, Morimatsu M, Nikami H, Yoshida T, and Saito M. Adrenergic activation of vascular endothelial growth factor mRNA expression in rat brown adipose tissue: implication in cold-induced angiogenesis. Biochem J 328: 179-183, 1997.
3. Autiero M, Luttun A, Tjwa M, and Carmeliet P. Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J Thromb Haemost 1: 1356-1370, 2003.
4. Basu S, Nagy JA, Pal S, Vasile E, Eckelhoefer IA, Bliss VS, Manseau EJ, Dasgupta PS, Dvorak HF, and Mukhopadhyay D. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med 7: 569-574, 2001.
5. Bernardini G, Ribatti D, Spinetti G, Morbidelli L, Ziche M, Santoni A, Capogrossi MC, and Napolitano M. Analysis of the role of chemokines in angiogenesis. J Immunol Methods 273: 83-101, 2003.
6. Blaes N and Boissel JP. Growth-stimulating effect of catecholamines on rat aortic smooth muscle cells in culture. J Cell Physiol 116: 167-172, 1983.
7. Bleeke T, Zhang H, Madamanchi N, Patterson C, and Faber JE. Catecholamine-induced vascular wall growth is dependent on generation of reactive oxygen species. Circ Res 94: 37-45, 2004.
8. 2-adrenoceptor subtype. Am J Respir Cell Mol Biol 19: 400-407, 1998.
9. 2 asphyxia increases plasma norepinephrine in rats via sympathetic nerves. Am J Physiol Regul Integr Comp Physiol 274: R19-R22, 1998.
10. Brandes RP, Role of NADPH oxidases in the control of vascular gene expression. Antioxid Redox Signal 5: 803-811, 2003.
11. Buschmann I, Heil M, Jost M, and Schaper W, Influence of inflammatory cytokines on arteriogenesis. Microcirculation 10: 371-379, 2003.
12. Candipan RC, Hsiun PT, Pratt R, and Cooke JP. Vascular injury augments adrenergic neurotransmission. Circulation 89: 777-784, 1994.
13. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, Vandendriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, and Persico MG. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7: 575-583, 2001.
14. Carmeliet P. Manipulating angiogenesis in medicine. J Intern Med 255: 538-561, 2004.
15. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6: 389-395, 2000.
16. Chae JK, Kim I, Lim ST, Chung MJ, Kim WH, Kim HG, Ko JK, and Koh GY. Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler Thromb Vasc Biol 20: 2573-2578, 2000.
17. 1-adrenoreceptor subtypes in vitro and in situ. J Biol Chem 270: 30980-30988, 1995.
18. 2, and iron are required for TNF-α-induced MCP-1 gene expression in endothelial cells: role of Rac1 and NADPH oxidase. Am J Physiol Heart Circ Physiol 286: H1001-H1007, 2004.
19. Cho MC, Rao M, Koch WJ, Thomas SA, Palmiter RD, and Rockman HA. Enhanced contractility and decreased β-adrenergic receptor kinase-1 in mice lacking endogenous norepinephrine and epinephrine. Circulation 99: 2702-2707, 1999.
20. -/- mice. Circulation 99: 3188-3198, 1999.
21. 1B-adrenoceptors in mouse. Physiol Genomics 9: 85-91, 2002.
22. Dao HH, Martens FM, Lariviere R, Yamaguchi N, Cernacek P, de Champlain J, and Moreau P. Transient involvement of endothelin in hypertrophic remodeling of small arteries. J Hypertens 19: 1801-1812, 2001.
23. Deindl E, Buschmann I, Hoefer IE, Podzuweit T, Boengler K, Vogel S, van Royen N, Fernandez B, and Schaper W. Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit. Circ Res 89: 779-786, 2001.
24. 2-adrenoceptors. Eur J Pharmacol 361: 1-15, 1998.
25. 1B-adrenergic receptor gene promoter region and hypoxia regulatory elements in vascular smooth muscle. Proc Natl Acad Sci USA 94: 9487-9492, 1997.
26. 1B-adrenergic receptor gene expression by arterial but not venous vascular smooth muscle. Am J Physiol Heart Circ Physiol 271: H1599-H1608, 1996.
27. Emanueli C, Salis MB, Pinna A, Graiani G, Manni L, and Madeddu P. Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs. Circulation 106: 2257-2262, 2002.
28. 1 receptor signalling modulates reparative angiogenesis induced by limb ischaemia. Br J Pharmacol 135: 87-92, 2002.
29. Erami C, Zhang H, Tanoue A, Tsujimoto G, Thomas SA, and Faber JE. Adrenergic catecholamine trophic activity contributes to flow-mediated arterial remodeling. Am J Physiol Heart Circ Physiol 289: H744-H753, 2005.
30. 1- Adrenoceptor stimulation directly induces growth of vascular wall in vivo. Am J Physiol Heart Circ Physiol 283: H1577-H1587, 2002.
31. 1- adrenoceptor subtypes by smooth muscle cells and adventitial fibroblasts in rat aorta and in cell culture. J Pharmacol Exp Ther 298: 441-452, 2001.
32. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, and Semenza GL. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613, 1996.
33. 2 receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation. Circ Res 88: 22-29, 2001.
34. Genaro AM, Sterin-Borda L, and Borda ES. β-Adrenoceptors in murine lymphocyte subpopulations: differential responsiveness to isoprenaline stimulation. Mol Neuropharma 3: 101-107, 1993.
35. Griffin SA, Brown WC, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, Mulvany MJ, and Lever AF. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 17: 626-635, 1991.
36. Gu W, Weihrauch D, Tanaka K, Tessmer JP, Pagel PS, Kersten JR, Chilian WM, and Warltier DC. Reactive oxygen species are critical mediators of coronary collateral development in a canine model. Am J Physiol Heart Circ Physiol 285: H1582-H1589, 2003.
37. Haigh JJ, Morelli PI, Gerhardt H, Haigh K, Tsien J, Damert A, Miquerol L, Muhlner U, Klein R, Ferrara N, Wagner EF, Betsholtz C, and Nagy A. Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling. Dev Biol 262: 225-241, 2003.
38. Hasko G, Shanley TP, Egnaczyk G, Nemeth ZH, Salzman AL, Vizi ES, and Szabo C. Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1α via a β-adrenoceptor- mediated mechanism. Br J Pharmacol 125: 1297-1303, 1998.
39. 1-adrenergic receptor mRNA expression in human monocytic cells and endothelial cells. J Neuroimmunol 125: 66-72, 2002.
40. Heil M, Ziegelhoeffer T, Pipp F, Kostin S, Martin S, Clauss M, and Schaper W. Blood monocyte concentration is critical for enhancement of collateral artery growth. Am J Physiol Heart Circ Physiol 283: H2411-H2419, 2002.
41. Helisch A and Schaper W. Arteriogenesis: the development and growth of collateral arteries. Microcirculation 10: 83-97, 2003.
42. Hershey JC, Baskin EP, Corcoran HA, Bett A, Dougherty NM, Gilberto DB, Mao X, Thomas KA, and Cook JJ. Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits. Heart Vessels 18: 142-149, 2003.
43. Hershey JC, Baskin EP, Glass JD, Hartman HA, Gilberto DB, Rogers IT, and Cook JJ. Revascularization in the rabbit hindlimb: dissociation between capillary sprouting and arteriogenesis. Cardiovasc Res 49: 618-625, 2001.
44. Hoefer IE, van Royen N, Rectenwald JE, Deindl E, Hua J, Jost M, Grundmann S, Voskuil M, Ozaki CK, Piek JJ, and Buschmann IR. Arteriogenesis proceeds via ICAM-1/Mac-1-mediated mechanisms. Circ Res 94: 1179-1185, 2004.
45. Johnson MD, Grignolo A, Kuhn CM, and Schanberg SM. Hypertension and cardiovascular hypertrophy during chronic catecholamine infusion in rats. Life Sci 33: 169-180, 1983.
46. Julius S. Corcoran Lecture. Sympathetic hyperactivity and coronary risk in hypertension. Hypertension 21: 886-893, 1993.
47. Kamiya A and Togawa T. Adaptive regulation of wall shear stress to flow change in the canine carotid artery. Am J Physiol Heart Circ Physiol 239: H14-H21, 1980.
48. Kersten JR, Pagel PS, Chilian WM, and Warltier DC. Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia. Cardiovasc Res 43: 44-57, 1999.
49. Kim HS, Lee G, John SW, Maeda N, and Smithies O. Molecular phenotyping for analyzing subtle genetic effects in mice: application to an angiotensinogen gene titration. Proc Natl Acad Sci USA. 99: 4602-4607, 2002.
50. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, and Epstein SE. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94: 678-685, 2004.
51. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S, Fuchs S, and Epstein SE. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109: 1543-1549, 2004.
52. Kleinjans J, Kasbergen C, Vervoort-Peters L, Smits J, and Struyker Boudier HA. Chronic intravenous infusion of noradrenaline produces labile hypertension in conscious rats. Life Sci 29: 509-514, 1981.
53. Krege JH, Kim HS, Moyer JS, Jennette JC, Peng L, Hiller SK, and Smithies O. Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis. Hypertension 29: 150-157, 1997.
54. Kusano KF, Allendoerfer KL, Munger W, Pola R, Bosch-Marce M, Kirchmair R, Yoon YS, Curry C, Silver M, Kearney M, Asahara T, and Losordo DW. Sonic hedgehog induces arteriogenesis in diabetic vasa nervorum and restores function in diabetic neuropathy. Arterioscler Thromb Vasc Biol 24: 2102-2107, 2004.
55. Lee CW, Stabile E, Kinnaird T, Shou M, Devaney JM, Epstein SE, and Burnett MS. Temporal patterns of gene expression after acute hindlimb ischemia in mice: insights into the genomic program for collateral vessel development. J Am Coll Cardiol 43: 474-482, 2004.
56. Lee EW, Michalkiewicz M, Kitlinska J, Kalezic I, Switalska H, Yoo PJ Sangkharat A, Ji H, Li L, Michalkiewicz T, Ljubisavljevic M, Johansson H, Grant DS, and Zukowska Z. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J Clin Invest 111: 1853-1862, 2003.
57. Lei L, Zhou R, Zheng W, Christensen LP, Weiss RM, and Tomanek RJ. Bradycardia induces angiogenesis, increases coronary reserve, and preserves function of the postinfarcted heart. Circulation 110: 796-802, 2004.
58. Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA, Hooper A, Priller J, De Klerck B, Compernolle V, Daci E, Bohlen P, Dewerchin M, Herbert JM, Fava R, Matthys P, Carmeliet G, Collen D, Dvorak HF, Hicklin DJ, and Carmeliet P. Revascularization of ischemic tissues by PIGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 8: 831-840, 2002.
59. 2-adrenoceptor agents on the production of monocytic products. Psychiatry Res 96: 245-253, 2000.
60. 1-adrenergic receptors on bone marrow cells. Exp Hematol 22: 313-320, 1994.
61. Maestroni GJ and Conti A. Noradrenergic modulation of lymphohematopoiesis. Int J Immunopharmacol 16: 117-122, 1994.
62. 1-Adrenergic plus angiotensin receptor blockade reduces atherosclerosis in apolipoprotein E-deficient mice. Hypertension 32: 1044-1048, 1998.
63. Nagel T, Resnick N, Atkinson WJ, Dewey CF Jr, and Gimbrone MA Jr. Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. J Clin Invest 94: 885-891, 1994.
64. Peirce SM and Skalak TC. Microvascular remodeling: a complex continuum spanning angiogenesis to arteriogenesis. Microcirculation 10: 99-111, 2003.
65. Ping P and Faber JE. Characterization of α-adrenoceptor gene expression in arterial and venous smooth muscle. Am J Physiol Heart Circ Physiol 265: H1501-H1509, 1993.
66. Polverini PJ. Role of the macrophage in angiogenesis-dependent diseases. EXS 79: 11-28, 1997.
67. Portbury AL, Chandra R, Groelle M, McMillian MK, Elias A, Herlong JR, Rios M, Roffler-Tarlov S, and Chikaraishi DM. Catecholamines act via a β-adrenergic receptor to maintain fetal heart rate and survival. Am J Physiol Heart Circ Physiol 284: H2069-H2077, 2003.
68. Price RJ, Less JR, Van Gieson EJ, and Skalak TC. Hemodynamic stresses and structural remodeling of anastomosing arteriolar networks: design principles of collateral arterioles. Microcirculation 9: 111-124, 2002.
69. Price RJ, Owens GK, and Skalak TC. Immunohistochemical identification of arteriolar development using markers of smooth muscle differentiation. Evidence that capillary arterialization proceeds from terminal arterioles. Circ Res 75: 520-527, 1994.
70. 1d-adrenergic receptor subtypes in human monocytes. J Neuroimmunol 95: 165-173, 1999.
71. 2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angiotensin II. Arterioscler Thromb Vasc Biol 17: 257-264, 1997.
72. Sasaki K, Murohara T, Ikeda H, Sugaya T, Shimada T, Shintani S, and Imaizumi T. Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. J Clin Invest 109: 603-611, 2002.
73. Satriano JA, Shuldiner M, Hora K, Xing Y, Shan Z, and Schlondorff D. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-α and immunoglobulin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J Clin Invest 92: 1564-1571, 1993.
74. Schaper W, Heil M, and Pipp F. Arteriogenesis: nature's way to maintain structure and metabolism in the presence of occluded arteries. Heart Metab 18: 21-27, 2002.
75. Schaper W and Scholz D. Factors regulating arteriogenesis. Arterioscler Thromb Vasc Biol 23: 1143-1151, 2003.
76. Schaper W. The Collateral Circulation of the Heart. Amsterdam: North Holland, 1971.
77. Scholz D, Cai WJ, and Schaper W. Arteriogenesis, a new concept of vascular adaptation in occlusive disease. Angiogenesis 4: 247-257, 2001.
78. Scholz D, Ito W, Fleming I, Deindl E, Sauer A, Wiesnet M, Busse R, Schaper J, and Schaper W. Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis). Virchows Arch 436: 257-270, 2000.
79. Scholz D, Ziegelhoeffer T, Helisch A, Wagner S, Friedrich C, Podzuweit T, and Schaper W. Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice. J Mol Cell Cardiol 34: 775-787, 2002.
80. Sellke FW, Wang SY, Friedman M, Harada K, Edelman ER, Grossman W, and Simons M. Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation. Am J Physiol Heart Circ Physiol 267: H1303-H1311, 1994.
81. Shyy JY, Lin MC, Han J, Lu Y, Petrime M, and Chien S. The cis-acting phorbol ester "12-O-tetradecanoylphorbol 13-acetate"-responsive element is involved in shear stress-induced monocyte chemotactic protein 1 gene expression. Proc Natl Acad Sci USA 92: 8069-8073, 1995.
82. Siddiqui AJ, Blomberg P, Wardell E, Hellgren I, Eskandarpour M, Islam KB, and Sylven C. Combination of angiopoietin-1 and vascular endothelial growth factor gene therapy enhances arteriogenesis in the ischemic myocardium. Biochem Biophys Res Commun 310: 1002-1009, 2003.
83. Spengler RN, Allen RM, Remick DG, Strieter RM, and Kunkel SL. Stimulation of α-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J Immunol 145: 1430-1434, 1990.
84. Springer ML, Ozawa CR, Banfi A, Kraft PE, Ip TK, Brazelton TR, and Blau HM. Localized arteriole formation directly adjacent to the site of VEGF-induced angiogenesis in muscle. Mol Ther 1: 441-449, 2003.
85. Stabile E, Burnett MS, Watkins C, Kinnaird T, Bachis A, la Sala A, Miller JM, Shou M, Epstein SE, and Fuchs S. Impaired arteriogenic response to acute hindlimb ischemia in CD4-knockout mice. Circulation 108: 205-210, 2003.
86. Sullivan CJ and Hoying JB. Flow-dependent remodeling in the carotid artery of fibroblast growth factor-2 knockout mice. Arterioscler Thromb Vasc Biol 22: 1100-1105, 2002.
87. -/- mice are hypotensive, have altered circadian rhythms, and have abnormal responses to dieting and stress. Am J Physiol Regul Integr Comp Physiol 286: R108-R113, 2004.
88. Tabor DR, Larry CH, and Jacobs RF. Differential induction of macrophage GSI-B4-binding activity. Leukoc Biol 45: 452-457, 1989.
89. 1-adrenoceptors in human peripheral blood lymphocytes. J Auton Pharmacol 20: 305-312, 2000.
90. Tayebjee MH, Lip GY, and MacFadyen RJ. Collateralization and the response to obstruction of epicardial coronary arteries. QJM 97: 259-272, 2004.
91. 1A-adrenoceptor antagonist inhibits neointimal growth after balloon injury of rat carotid artery. Am J Physiol Heart Circ Physiol 284: H385-H392, 2003.
92. Teunis MA, Kavelaars A, Voest E, Bakker JM, Ellenbroek BA, Cools AR, and Heijnen CJ. Reduced tumor growth, experimental metastasis formation, and angiogenesis in rats with a hyperreactive dopaminergic system. FASEB J 16: 1465-1467, 2002.
93. Thomas SA, Marck BT, Palmiter RD, and Matsumoto AM. Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine β-hydroxylase. J Neurochem 70: 2468-2476, 1998.
94. Unthank JL, Fath SW, Burkhart HM, Miller SC, and Dalsing MC. Wall remodeling during luminal expansion of mesenteric arterial collaterals in the rat. Circ Res 79: 1015-1023, 1996.
95. Ushio-Fukai M and Alexander RW. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol Cell Biochem 264: 85-97, 2004.
96. 1b-adrenergic receptor defect in mice. Circulation 105: 1700-1707, 2002.
97. Vincent KA, Shyu KG, Luo Y, Magner M, Tio RA, Jiang C, Goldberg MA, Akita GY, Gregory RJ, and Isner JM. Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1α/VP16 hybrid transcription factor. Circulation 102: 2255-2261, 2000.
98. Weil J, Benndorf R, Fredersdorf S, Griese DP, and Eschenhagen T. Norepinephrine upregulates vascular endothelial growth factor in rat cardiac myocytes by a paracrine mechanism. Angiogenesis 6: 303-309, 2003.
99. White FC and Bloor CM. Coronary vascular remodeling and coronary resistance during chronic ischemia. Am J Cardiovasc Pathol 4: 193-202, 1992.
100. White FC, Carroll SM, Magnet A, and Bloor CM. Coronary collateral development in swine after coronary artery occlusion. Circ Res 71: 1490-1500, 1992.
101. Wiedeman MP. Architecture. In: Handbook of Physiology. The Cardiovascular System. Microcirculation. Bethesda, MD: Am. Physiol. Soc., 1984, sect. 2, vol. IV, pt. 1, p. 11-40.
102. 1D-Adrenergic receptors and mitogen-activated protein kinase mediate increased protein synthesis by arterial smooth muscle. Mol Pharmacol 51: 764-775, 1997.
103. 1-like receptors. Arterioscler Thromb Vasc Biol 17: 3164-3173, 1997.
104. Yu SM, Tsai SY, Guh JH, Ko FN, Teng CM, and Ou JT. Mechanism of catecholamine-induced proliferation of vascular smooth muscle cells. Circulation 94: 547-554, 1996.
105. Zhang H, Chalothorn D, Jackson L, Lee DC, and Faher JE. Transactivation of epidermal growth factor receptor mediates catecholamine-induced growth of vascular smooth muscle. Circ Res 95: 989-997, 2004.
106. 1- adrenoceptors demonstrates involvement of catecholamines in vascular remodeling. Am J Physiol Heart Circ Physiol 287: H2106-H2114, 2004.
107. 1-adrenoceptor subtypes. Circ Res 89: 815-822, 2001.
108. Zhang H, Facemire CS, Banes AJ, and Faber JE. Different α-adrenoceptors mediate migration of vascular smooth muscle cells and adventitial fibroblasts in vitro. Am J Physiol Heart Circ Physiol 282: H2364-H2370, 2002.
109. Ziegelhoeffer T, Fernandez B, Kostin S, Heil M, Voswinckel R, Helisch A, and Schaper W. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 94: 230-238, 2004.